Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Sanz Pamplona, Rebeca ^a   Berenguer, Antoni ^a   Cordero, David ^a   Riccadonna, Samantha ^b   Solé, Xavier ^a   Crous Bou, Marta ^a   Guinó, Elisabet ^a   Sanjuan, Xavier ^a   Biondo, Sebastiano ^a,c   Soriano, Antonio ^a   Jurman, Giuseppe ^b   Capella, Gabriel ^a   Furlanello, Cesare ^b   Moreno, Victor ^a,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b FONDAZIONE BRUNO KESSLER   (Italy)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AD09MSI GENE; AD09MSS GENE; AJ08 GENE; AR05 GENE; ARTICLE; BD07 GENE; BR05 GENE; BR06 GENE; BT04 GENE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CLASSIFIER; CLINICAL DATA REPOSITORY; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DRUG DISCRIMINATION; EC05 GENE; GENE; GENE EXPRESSION SIGNATURE; GENE EXPRESSION SYSTEM; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC DATABASE; HO09 GENE; HUMAN; INFORMATION PROCESSING; JG08 GENE; JS09 GENE; KL10 GENE; KN11 GENE; LC09 GENE; LN07G GENE; LN07NZ GENE; MICROSATELLITE INSTABILITY; MT10 GENE; NUCLEOTIDE SEQUENCE; OC10 GENE; PG10 GENE; PL10 GENE; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROBABILITY; REPRODUCIBILITY; SC09 GENE; SENSITIVITY AND SPECIFICITY; SL10 GENE; SM09 GENE; ST09 GENE; SYSTEMATIC REVIEW; VALIDATION PROCESS; VL10 GENE; WG04 GENE; WN10 GENE; WT09 GENE; WT10 GENE; YM06 GENE;

COLORECTAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; TRANSCRIPTOME;

EID: 84868674633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048877     Document Type: Article

References (85)

1. Ferlay J, Parkin DM, Steliarova-Foucher E, (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4): 765-81.
2. Saltz LB, Kelsen DP, (1997) Adjuvant treatment of colorectal cancer. Annu Rev Med 48: 191-202.
3. Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22(16): 3408-19.
4. Gill S, Loprinizi CL, Sargent DJ, Thome SD, Alberts SR, et al. (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?. J Clin Oncol 22(10): 1797-806.
5. McMillan DC, McArdle CS, Morrison DS, (2010) A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer. Br J Cancer. 103(7): 970-4.
6. Dotan E, Cohen SJ, (2011) Challenges in the management of stage II colon cancer. Semin Oncol 38(4): 511-20.
7. Portera CA Jr, Berman RS, Ellis LM, (1998) Molecular determinants of colon cancer metastasis. Surg Oncol 7(3-4): 183-95.
8. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A 105(11): 4283-8.
9. George B, Kopetz S, (2011) Predictive and prognostic markers in colorectal cancer. Curr Oncol Rep 13(3): 206-15.
10. Cowin PA, Anglesio M, Etemadmoghadam D, Bowtell DD, (2010) Profiling the cancer genome. Annu Rev Genomics Hum Genet 11: 133-59.
11. Kim C, Paik S, (2010) Gene-expression-based prognostic assays for breast cancer. Nat Rev Clin Oncol 7(6): 340-7.
12. Slodkowska EA, Ross JS, (2009) MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Expert Rev Mol Diagn 9(5): 417-22.
13. Moher D, Liberati A, Tetzlaff J, (2009) Altman DG; PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 21 6(7): e1000097.
14. Andersen CL, Christensen LL, Thorsen K, Schepeler T, Sorensen FB, et al. (2009) Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer 100(3): 511-23.
15. Anjomshoaa A, Lin YH, Black MA, McCall JL, Humar B, et al. (2008) Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer. Br J Cancer 99(6): 966-73.
16. Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, et al. (2005) Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129(3): 874-84.
17. Bandres E, Malumbres R, Cubedo E, Honorato B, Zarate R, et al. (2007) A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients. Oncol Rep 17(5): 1089-94.
18. Barrier A, Boelle PY, Roser F, Gregg J, Tse C, et al. (2006) Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 24(29): 4685-91.
19. Barrier A, Lemoine A, Boelle PY, Tse C, Brault D, et al. (2005) Colon cancer prognosis prediction by gene expression profiling. Oncogene 24(40): 6155-64.
20. Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, et al. (2004) Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23(7): 1377-91.
21. Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, et al. (2005) Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23(15): 3526-35.
22. Hao JM, Chen JZ, Sui HM, Si-Ma XQ, Li GQ, et al. (2010) Five-gene signature as a potential predictor of metastasis and survival in colorectal cancer. J Pathol 220(4): 475-89.
23. Jiang Y, Casey G, Lavery IC, Zhang Y, Talantov D, et al. (2008) Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer. J Mol Diagn 10(4): 346-54.
24. Jorissen RN, Gibbs P, Christie M, Prakash S, Lipton L, et al. (2009) Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer. Clin Cancer Res 15(24): 7642-7651.
25. Kalady MF, Dejulius K, Church JM, Lavery IC, Fazio VW, (2010) Gene signature is associated with early stage rectal cancer recurrence. J Am Coll Surg 211(2): 187-95.
26. Kennedy RD, Bylesjo M, Kerr P, Davison T, Black JM, et al. (2011) Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue. J Clin Oncol 29(35): 4620-6.
27. Liersch T, Grade M, Gaedcke J, Varma S, Difilippantonio MJ, et al. (2009) Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence. Cancer Genet Cytogenet. 190(2): 57-65.
28. Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, et al. (2007) Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clin Cancer Res 13(2 Pt 1): 498-507.
29. Mettu RK, Wan YW, Habermann JK, Ried T, Guo NL, (2010) A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types. Int J Biol Markers 25(4): 219-28.
30. O'Connell MJ, Lavery I, Yothers G, Paik S, Clark-Langone KM, et al. (2010) Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. J Clin Oncol 28(25): 3937-44.
31. Peng J, Wang Z, Chen W, Ding Y, Wang H, et al. (2010) Integration of genetic signature and TNM staging system for predicting the relapse of locally advanced colorectal cancer. Int J Colorectal Dis 25(11): 1277-85.
32. Pillaire MJ, Selves J, Gordien K, Gourraud PA, Gentil C, et al. (2010) A 'DNA replication' signature of progression and negative outcome in colorectal cancer. Oncogene 29(6): 876-87.
33. Salazar R, Roepman P, Capella G, Moreno V, Simon I, et al. (2011) Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J Clin Oncol 29(1): 17-24.
34. Schetter AJ, Nguyen GH, Bowman ED, Mathe EA, Yuen ST, et al. (2009) Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res15(18): 5878-87.
35. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, et al. (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138(3): 958-68.
36. Staub E, Groene J, Heinze M, Mennerich D, Roepcke S, et al. (2009) An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types. J Mol Med (Berl) 87(6): 633-44.
37. Van Laar RK, (2010) An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer. Br J Cancer 103(12): 1852-7.
38. Wan YW, Quian Y, Rathanagiriswaran S, Castranova V, Guo NL, (2010) A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types. Oncol Rep 24(2): 489-94.
39. Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, et al. (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22(9): 1564-71.
40. Watanabe T, Kobunai T, Sakamoto E, Yamamoto Y, Konishi T, et al. (2009) Gene expression signature for recurrence in stage III colorectal cancers. Cancer 115(2): 283-92.
41. Watanabe T, Kobunai T, Yamamoto Y, Kanazawa T, Konishi T, et al. (2010) Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes. Eur J Cancer. 46(11): 2119-26.
42. Yamasaki M, Takemasa I, Komori T, Watanabe S, Sekimoto M, et al. (2007) The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 30(1): 129-38.
43. Gray RG, Quirke P, Handley K, Lopatin M, Magill L, et al. (2011) Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. J Clin Oncol 10 29(35): 4611-9.
44. Barrett T, Edgar R, (2006) Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol 411: 352-69.
45. Parkinson H, Sarkans U, Shojatalab M, Abeygunawardena N, Contrino S, et al. (2005) ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 33(Database issue): D553-5.
46. UniProt Consortium (2011) Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res 39(Database issue): D214-9.
47. Povey S, Lovering R, Bruford E, Wright M, Lush M, et al. (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109(6): 678-80.
48. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, et al. (2003) NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 31(1): 82-6.
49. Breiman L, (2001) Random Forest. Machine Learning 45(1): 5-32.
50. Breiman L (2002) Manual On Setting Up, Using, And Understanding Random Forests V3.1. Available: http://oz.berkeley.edu/users/breiman/Using_random_forests_V3.1.pdf.
51. Mitchell MW (2011) Bias of the Random Forest Out-of-Bag (OOB) Error for Certain Input Parameters. Open Journal of Statistics doi:10.4236/ojs.2011.13024.
52. Liaw A, Wiene M, (2002) Classification and regression by randomForest. R News 2(3): 18-22.
53. Hastie T, Tibshirani R, Friedman J (2008) The Elements of Statistical Learning (2nd edition). Springer-Verlag.
54. Vapnik V (1998) Statistical Learning Theory. Wiley, New York.
55. Liu XY, Wu J, Zhou ZH, (2009) Exploratory undersampling for class-imbalance learning. IEEE Trans Syst Man Cybern B Cybern 39(2): 539-50.
56. Hastie T (2009) svmpath: the SVM Path algorithm. R package version 0.93. Available: http://CRAN.R-project.org/package=svmpath.
57. Baldi P, Brunak S, Chauvin Y, Andersen CA, Nielsen H, (2000) Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics 16(5): 412-24.
58. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, et al. (2010) The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 28(8): 827-38.
59. Zhou XH, Obuchowsky NA, McClish D (2002) Statistical Mehods in diagnostic Medicine. Wiley.
60. Braga-Neto UM, Dougherty ER, (2004) Is cross-validation valid for small-sample microarray classification? Bioinformatics 12 20(3): 374-80.
61. Strasser H, Weber C (1999) On the asymptotic theory of permutation statistics. Mathematical Methods of Statistics 8, 220-250.
62. Hothorn T, Hornik K, van de Wiel MA, Zeileis A (2008) Implementing a class of permutation test: the coin package. Journal of Statistical Software 28(8),1-23.
63. Efron B, Tibshirani R (1993) An Introduction to the Bootstrap. Chapman & Hall.
64. Canty A, Ripley B (2011) boot: Bootstrap R (S-Plus) Functions. R package version 1.3-2.
65. Lusa L, McShane LM, Radmacher MD, Shih JH, Wright GW, et al. (2007) Appropriateness of some resampling-based inference procedures for assessing performance of prognostic classifiers derived from microarray data. Stat Med 28 26(5): 1102-13.
66. Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, et al. (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370(9604): 2020-9.
67. Lu AT, Salpeter SR, Reeve AE, Escrich S, Johnston PG, et al. (2009) Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis. Clin Colorectal Cancer 8(4): 207-14.
68. Simon R, (2005) Roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol 10 23(29): 7332-41.
69. Dupuy A, Simon RM, (2007) Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 17 99(2): 147-57.
70. Raspe E, Decraene C, Berx G (2012) Gene expression profiling to dissect the complexity of cancer biology: Pitfalls and promise. Semin Cancer Biol. Mar 7.
71. Ioannidis JP, Allison DB, Ball CA, Coulibaly I, Cui X, et al. (2009) Repeatability of published microarray gene expression analyses. Nat Genet. 2009 41(2): 149-55.
72. Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, et al. (2005) Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 1 23(34): 8664-70.
73. Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, et al. (2007) End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol 10 25(29): 4569-74.
74. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 7 100(1): 57-70.
75. Barry WT, Kernagis DN, Dressman HK, Griffis RJ, Hunter JD, et al. (2010) Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. J Clin Oncol 1 28(13): 2198-206.
76. Esposito G, (2007) Complementary techniques: laser capture microdissection-increasing specificity of gene expression profiling of cancer specimens. Adv Exp Med Biol 593: 54-65.
77. Cardoso J, Boer J, Morreau H, Fodde R, (2007) Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta 1775(1): 103-37.
78. Abba MC, Lacunza E, Butti M, Aldaz CM, (2010) Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures. Biomark Insights 27 5: 103-18.
79. Lascorz J, Chen B, Hemminki K, Forsti A, (2011) Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies. PLoS One 6(4): e18867.
80. Sole X, Bonifaci N, Lopez-Bigas N, Berenguer A, Hernandez P, et al. (2009) Biological convergence of cancer signatures. PLoS One 4(2): p. e4544.
81. Sanz-Pamplona R, Cordero D, Berenguer A, Lejbkowicz F, Rennert H, et al. (2011) Gene expression differences between colon and rectum tumors. Clin Cancer Res 1 17(23): 7303-12.
82. Syk E, Glimelius B, Nilsson PJ, (2010) Factors influencing local failure in rectal cancer: analysis of 2315 patients from a population-based series. Dis Colon Rectum 53(5): 744-52.
83. Diaz-Uriarte R, Alvarez de Andres S, (2006) Gene selection and classification of microarray data using random forest. BMC Bioinformatics 7: 3.
84. Dudoit S, Fridlyand J, Speed TP, (2002) Comparison of discrimination methods for classification of tumors using gene expression data. J Am Stat Assoc 97: 77-87.
85. Webber EM, Lin JS, Evelyn P Whitlock (2010) Oncotype DX tumor gene expression profiling in stage II colon cancer. Application: prognostic, risk prediction. PLoS Curr 2;2.